Funding news
Reprogram Biosciences logo

Reprogram Biosciences Secures $6.0M

Recently funded · $6.0M SeedHospitals and Health CareUSView source

Get the full Reprogram Biosciences company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Reprogram Biosciences, a biotech startup pioneering a new strategy to fight cancer by converting harmful cells into beneficial immune cells, has closed a $6.0M seed funding round.

The capital infusion will advance its unique cell reprogramming technology, which aims to directly transform disease-causing cells inside the body. This innovative approach promises not only safer and more accessible cancer treatments but also holds significant potential to revolutionize therapies for a wide array of other diseases, simplifying effective solutions for patients.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
DCO Energy, LLC logo

DCO Energy, LLC

United States

$5.5M
2
Navigate AI logo

Navigate AI

United Kingdom

$25.0M
3
Cypher AI logo

Cypher AI

United States

$2.0M
4
Sorce logo

Sorce

United States

$500.0K
5
Itera logo

Itera

Norway

$12.0M